申请人:Takeda Chemical Industries, Ltd.
公开号:EP0643050A1
公开(公告)日:1995-03-15
A new 2,4-oxazolidinedione derivative is provided possessing excellent hypoglycemic and hypolipidemic activities.
The invention relates to a 2,4-oxazolidinedione derivative represented by the general formula:
wherein X represents -CH₂-, -C(=O)-, -CH(OH)-, -C(=NOH)- or -CH=CH-; R represents a hydrocarbon residue or heterocyclic group which may be substituted; n represents an integer from 0 to 5, and m represents an integer from 1 to 3; ········ represents a single or double bond; provided that n is an integer from 1 to 5 when X is -C(=O)-,or a pharmacologically acceptable salt thereof.
本发明提供了一种新的 2,4-噁唑烷二酮衍生物,具有优异的降血糖和降血脂活性。
本发明涉及一种由通式表示的 2,4-噁唑烷二酮衍生物:
其中X代表-CH₂-、-C(=O)-、-CH(OH)-、-C(=NOH)-或-CH=CH-;R代表可被取代的烃残基或杂环基团;n代表0至5的整数,m代表1至3的整数;--------代表单键或双键;但当X为-C(=O)-时,n为1至5的整数,或其药理学上可接受的盐。